Dr. Fink is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3402 W Dr Martin Luther King Jr Blvd
Tampa, FL 33607Phone+1 813-875-3950Fax+1 813-876-0432
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2004
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2002
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1997 - 2000
- New York Medical CollegeClass of 1997
Certifications & Licensure
- FL State Medical License 2004 - 2026
- NY State Medical License 1998 - 2007
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Publications & Presentations
PubMed
- 14 citationsNovel therapeutic agents under investigation for malignant melanomaAnna C. Pavlick, Sylvia Adams, Matthew A Fink, Amanda Bailes
Expert Opinion on Investigational Drugs. 2003-09-01 - Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.Lucio N Gordan, David Ray, Stephen C Ijioma, George Dranitsaris, Amanda Warner
Current Oncology. 2024-01-14
Press Mentions
- Florida Cancer Specialists & Research Institute Best Practices Program Improves Treatment Response and Survival for Patients with Multiple MyelomaJanuary 30th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: